1. Home
  2. CHWY vs VTRS Comparison

CHWY vs VTRS Comparison

Compare CHWY & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHWY
  • VTRS
  • Stock Information
  • Founded
  • CHWY 2010
  • VTRS 1961
  • Country
  • CHWY United States
  • VTRS United States
  • Employees
  • CHWY N/A
  • VTRS N/A
  • Industry
  • CHWY Catalog/Specialty Distribution
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • CHWY Consumer Discretionary
  • VTRS Health Care
  • Exchange
  • CHWY Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • CHWY 13.4B
  • VTRS 13.0B
  • IPO Year
  • CHWY 2019
  • VTRS N/A
  • Fundamental
  • Price
  • CHWY $35.11
  • VTRS $11.25
  • Analyst Decision
  • CHWY Buy
  • VTRS Hold
  • Analyst Count
  • CHWY 24
  • VTRS 3
  • Target Price
  • CHWY $36.80
  • VTRS $13.67
  • AVG Volume (30 Days)
  • CHWY 3.9M
  • VTRS 9.5M
  • Earning Date
  • CHWY 03-19-2025
  • VTRS 02-27-2025
  • Dividend Yield
  • CHWY N/A
  • VTRS 4.27%
  • EPS Growth
  • CHWY 2618.71
  • VTRS N/A
  • EPS
  • CHWY 0.92
  • VTRS N/A
  • Revenue
  • CHWY $11,439,853,000.00
  • VTRS $15,048,500,000.00
  • Revenue This Year
  • CHWY $8.43
  • VTRS N/A
  • Revenue Next Year
  • CHWY $5.28
  • VTRS N/A
  • P/E Ratio
  • CHWY $38.19
  • VTRS N/A
  • Revenue Growth
  • CHWY 3.53
  • VTRS N/A
  • 52 Week Low
  • CHWY $14.69
  • VTRS $9.93
  • 52 Week High
  • CHWY $40.09
  • VTRS $13.62
  • Technical
  • Relative Strength Index (RSI)
  • CHWY 37.21
  • VTRS 52.72
  • Support Level
  • CHWY $36.52
  • VTRS $10.74
  • Resistance Level
  • CHWY $38.21
  • VTRS $11.02
  • Average True Range (ATR)
  • CHWY 1.38
  • VTRS 0.21
  • MACD
  • CHWY -0.41
  • VTRS 0.08
  • Stochastic Oscillator
  • CHWY 8.49
  • VTRS 91.82

About CHWY Chewy Inc.

Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: